FDA Bans Artificial Dye Red 3 From Food
Consumer advocacy groups petitioned agency to restrict additive initially approved for use in 1969.
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Offering quick way for ERs to treat a deadly condition, South Bay company scores FDA OK
Sepsis, the leading cause of death in U.S. hospitals killing about 350,000 people annually, is an extreme response to an ...
ImmunityBio Shares Climb After Company Previews FY25 Regulatory Advances
ImmunityBio also said it will submit a regulatory filing for an alternative source of Bacillus Calmette-Guerin, a drug which treats bladder cancer. The company expects to produce large quantities of ...
Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?
Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before ...
A wave of cat deaths from bird flu prompts new rules on pet food production
Cats — both large cats in captivity and pet house cats — across multiple states have been dying from H5N1 bird flu. Now, ...
FiercePharma10d
Y-mAbs splits from commercial chief, tasks new hire with growing cancer drug sales
Y-mAbs Therapeutics is parting ways with its chief commercial officer and putting a new hire in charge of the cancer drug Danyelza. The biotech made the changes, which include “a small ...
Business Wire5d
Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
FDA Accepts Arrowhead Pharmaceuticals' Drug Application for Genetic Disease Treatment
Arrowhead Pharmaceuticals said Friday that the Food and Drug Administration accepted the company's new drug application for its treatment of familial chylomicronemia syndrome, a severe and rare ...
GRAIL: Cash Burn And Commercialization Timeline Are Problematic
GRAIL is advancing blood-based cancer detection with Galleri. Find out why GRAL stock’s future hinges on successful trials ...
Rep. Ritchie Torres blasts Gov. Hochul for ‘passive’ stance to NYC junkie wasteland known as ‘The Hub’
The Governor would never tolerate an open-air drug market outside of the governor’s mansion,” the Democratic Bronx pol wrote ...
Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...